Correlation Between Inhibrx and Relief Therapeutics
Can any of the company-specific risk be diversified away by investing in both Inhibrx and Relief Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibrx and Relief Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibrx and Relief Therapeutics Holding, you can compare the effects of market volatilities on Inhibrx and Relief Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibrx with a short position of Relief Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibrx and Relief Therapeutics.
Diversification Opportunities for Inhibrx and Relief Therapeutics
0.03 | Correlation Coefficient |
Significant diversification
The 3 months correlation between Inhibrx and Relief is 0.03. Overlapping area represents the amount of risk that can be diversified away by holding Inhibrx and Relief Therapeutics Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Relief Therapeutics and Inhibrx is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibrx are associated (or correlated) with Relief Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Relief Therapeutics has no effect on the direction of Inhibrx i.e., Inhibrx and Relief Therapeutics go up and down completely randomly.
Pair Corralation between Inhibrx and Relief Therapeutics
If you would invest 313.00 in Relief Therapeutics Holding on September 14, 2024 and sell it today you would earn a total of 0.00 from holding Relief Therapeutics Holding or generate 0.0% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Insignificant |
| Accuracy | 0.4% |
| Values | Daily Returns |
Inhibrx vs. Relief Therapeutics Holding
Performance |
| Timeline |
| Inhibrx |
| Relief Therapeutics |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Inhibrx and Relief Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibrx and Relief Therapeutics
The main advantage of trading using opposite Inhibrx and Relief Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibrx position performs unexpectedly, Relief Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Relief Therapeutics will offset losses from the drop in Relief Therapeutics' long position.| Inhibrx vs. Crinetics Pharmaceuticals | Inhibrx vs. Merus BV | Inhibrx vs. Lyell Immunopharma | Inhibrx vs. Kronos Bio |
| Relief Therapeutics vs. China Clean Energy | Relief Therapeutics vs. Ecoloclean Industrs | Relief Therapeutics vs. Constellation Brands Class | Relief Therapeutics vs. Tenaris SA ADR |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities |